The only CSF biomarker differing at baseline was GFAP, found to be elevated in patients with PD with hyposmia compared to those with normal olfactory function (12.25 ± 3.87 vs 10.46 ± 3.68, p = 0.001, Table 2, Fig S1, Supporting material). Here, GFAP is linked to Parkinson disease.